Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line - PubMed (original) (raw)
Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line
D Guivarc'h et al. Endocrinology. 1998 Oct.
Abstract
The two isoforms of the D2 dopamine receptor are generated by alternative splicing of the exon 6 of the premessenger RNA (pre-mRNA), changing the length of the third cytoplasmic loop involved in the coupling to G proteins. In the MMQ PRL cell line, sex steroid hormones modulated the proportion of the two D2 receptor isoforms. Under controlled culture conditions, 17beta-estradiol (E2) strongly favored the production of the long isoform of D2 mRNA over the short one, whereas both isoforms were equally abundant when culture medium was hormone depleted. In the presence of progesterone (P), E2 action was inhibited, and equal amounts of each D2 receptor isoform were produced in the cells. Hormone treatments never modified either the total amount of D2 receptor mRNA and D2 receptor binding sites or D2 receptor-mediated inhibition of adenylyl cyclase. Specific antagonists demonstrated that the activity of each hormone depended on their nuclear receptors. Inhibitors of gene transcription or translation also showed that their activity required protein synthesis. The expression of the short D2 receptor isoform was never prominent, even at the single cell level. Analysis of the intron sequence flanking alternative exon 6 showed that only the upstream intron presented two sequence tracts known to be targets for splicing factors. Taken together, these results provide converging evidence for a physiologically relevant mechanism by which sex steroid receptors could regulate the expression of a splicing factor favoring the production of the long dopamine D2 receptor isoform.
Similar articles
- Sex steroid hormones change the differential distribution of the isoforms of the D2 dopamine receptor messenger RNA in the rat brain.
Guivarc'h D, Vernier P, Vincent JD. Guivarc'h D, et al. Neuroscience. 1995 Nov;69(1):159-66. doi: 10.1016/0306-4522(95)00228-b. Neuroscience. 1995. PMID: 8637614 - Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.
Oomizu S, Boyadjieva N, Sarkar DK. Oomizu S, et al. Alcohol Clin Exp Res. 2003 Jun;27(6):975-80. doi: 10.1097/01.ALC.0000071743.57855.BE. Alcohol Clin Exp Res. 2003. PMID: 12824819 Free PMC article. - Absence of D2S dopamine receptor in the prolactin-secreting MMQ pituitary clone: characterization of a wild D2L receptor coupled to native transduction mechanisms.
Ventra C, Meucci O, Grimaldi M, Scorziello A, Porcellini A, Schettini G. Ventra C, et al. J Mol Endocrinol. 1995 Jun;14(3):375-89. doi: 10.1677/jme.0.0140375. J Mol Endocrinol. 1995. PMID: 7669227 - Dopamine D2 receptors in signal transduction and behavior.
Picetti R, Saiardi A, Abdel Samad T, Bozzi Y, Baik JH, Borrelli E. Picetti R, et al. Crit Rev Neurobiol. 1997;11(2-3):121-42. doi: 10.1615/critrevneurobiol.v11.i2-3.20. Crit Rev Neurobiol. 1997. PMID: 9209827 Review. - Quantitation of isotypes of D2 receptors using solution hybridization.
Artymyshyn RP, Ivins KJ, Monks BR, Luedtke RR, Molinoff PB. Artymyshyn RP, et al. Neurochem Int. 1992 Mar;20 Suppl:189S-195S. doi: 10.1016/0197-0186(92)90237-l. Neurochem Int. 1992. PMID: 1365424 Review.
Cited by
- Approach to the Patient With Prolactinoma.
Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R. Auriemma RS, et al. J Clin Endocrinol Metab. 2023 Aug 18;108(9):2400-2423. doi: 10.1210/clinem/dgad174. J Clin Endocrinol Metab. 2023. PMID: 36974474 Free PMC article. Review. - Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
Pivonello C, Patalano R, Negri M, Pirchio R, Colao A, Pivonello R, Auriemma RS. Pivonello C, et al. Front Endocrinol (Lausanne). 2022 Jan 12;12:791633. doi: 10.3389/fendo.2021.791633. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35095761 Free PMC article. Review. - Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.
Lin TY, Huang WL, Lee WY, Luo CW. Lin TY, et al. PLoS One. 2015 Aug 28;10(8):e0136836. doi: 10.1371/journal.pone.0136836. eCollection 2015. PLoS One. 2015. PMID: 26317338 Free PMC article. - Homer1 alternative splicing is regulated by gonadotropin-releasing hormone and modulates gonadotropin gene expression.
Wang Q, Chikina MD, Pincas H, Sealfon SC. Wang Q, et al. Mol Cell Biol. 2014 May;34(10):1747-56. doi: 10.1128/MCB.01401-13. Epub 2014 Mar 3. Mol Cell Biol. 2014. PMID: 24591653 Free PMC article. - Roles of dopamine 2 receptor isoforms and g proteins in ethanol regulated prolactin synthesis and lactotropic cell proliferation.
Sengupta A, Sarkar DK. Sengupta A, et al. PLoS One. 2012;7(9):e45593. doi: 10.1371/journal.pone.0045593. Epub 2012 Sep 18. PLoS One. 2012. PMID: 23029123 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources